These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 2880735
21. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Nash JF, Nichols DE. Eur J Pharmacol; 1991 Jul 23; 200(1):53-8. PubMed ID: 1722755 [Abstract] [Full Text] [Related]
22. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JE, Kolta M, Slikker W. Neurotoxicology; 1989 Jul 23; 10(3):455-66. PubMed ID: 2576302 [Abstract] [Full Text] [Related]
23. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Feuerstein TJ, Hertting G, Lupp A, Neufang B. Br J Pharmacol; 1986 Jul 23; 88(3):677-84. PubMed ID: 3742155 [Abstract] [Full Text] [Related]
24. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine. Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE. Eur J Pharmacol; 1990 Nov 20; 191(1):1-10. PubMed ID: 1982656 [Abstract] [Full Text] [Related]
25. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME. J Neurosci; 1988 Aug 20; 8(8):2788-803. PubMed ID: 2457659 [Abstract] [Full Text] [Related]
26. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Chu T, Kumagai Y, DiStefano EW, Cho AK. Biochem Pharmacol; 1996 Mar 22; 51(6):789-96. PubMed ID: 8602874 [Abstract] [Full Text] [Related]
27. Drug discrimination studies with MDMA and amphetamine. Oberlender R, Nichols DE. Psychopharmacology (Berl); 1988 Mar 22; 95(1):71-6. PubMed ID: 2898791 [Abstract] [Full Text] [Related]
28. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices. Iravani MM, Asari D, Patel J, Wieczorek WJ, Kruk ZL. Synapse; 2000 Jun 15; 36(4):275-85. PubMed ID: 10819905 [Abstract] [Full Text] [Related]
29. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices. Fitzgerald JL, Reid JJ. Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar 15; 347(3):313-23. PubMed ID: 8097569 [Abstract] [Full Text] [Related]
30. 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW. Eur J Pharmacol; 1987 Jun 04; 137(2-3):265-8. PubMed ID: 2886355 [Abstract] [Full Text] [Related]
31. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK. Eur J Pharmacol; 1989 Aug 29; 167(3):375-83. PubMed ID: 2572435 [Abstract] [Full Text] [Related]
32. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release. Azmitia EC, Murphy RB, Whitaker-Azmitia PM. Brain Res; 1990 Feb 26; 510(1):97-103. PubMed ID: 1969761 [Abstract] [Full Text] [Related]
33. A simple organ bath for electrical stimulation and superfusion of rat brain slices. Hoffman AJ, Maxwell DM, Nichols DE. J Pharmacol Methods; 1986 Nov 26; 16(3):185-99. PubMed ID: 3784567 [Abstract] [Full Text] [Related]
34. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates. Hiramatsu M, DiStefano E, Chang AS, Cho AK. Eur J Pharmacol; 1991 Nov 05; 204(2):135-40. PubMed ID: 1725282 [Abstract] [Full Text] [Related]
35. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity. Oberlender R, Nichols DE. J Pharmacol Exp Ther; 1990 Dec 05; 255(3):1098-106. PubMed ID: 1979813 [Abstract] [Full Text] [Related]
36. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. Callaway CW, Wing LL, Geyer MA. J Pharmacol Exp Ther; 1990 Aug 05; 254(2):456-64. PubMed ID: 1974635 [Abstract] [Full Text] [Related]
37. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan. Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK. Eur J Pharmacol; 1990 Mar 27; 178(3):313-20. PubMed ID: 1971220 [Abstract] [Full Text] [Related]
38. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY, Hsu FL. Pharmacol Biochem Behav; 1991 Jul 27; 39(3):787-90. PubMed ID: 1723801 [Abstract] [Full Text] [Related]
39. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Colado MI, Williams JL, Green AR. Br J Pharmacol; 1995 Aug 27; 115(7):1281-9. PubMed ID: 7582557 [Abstract] [Full Text] [Related]
40. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Paulus MP, Geyer MA. Neuropsychopharmacology; 1992 Aug 27; 7(1):15-31. PubMed ID: 1355968 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]